Immunoconsulting Limited is a consulting firm that assists biopharmaceutical companies developing new therapeutic strategies which target components of the immune system across all therapy areas.
Andrew Leishman, PhD, Director of Immunoconsulting Limited has over 20 years of experience in the biotechnology and pharmaceutical industry.
How does TherapeutAix work with Immunoconsulting Limited?
The combined expertise of Immunoconsulting limited and TherapeutAix ensures that we are able to provide high quality analysis and support to clients with projects that have an immunology focus, particularly in the immuno-oncology space.
Working together with Immunoconsulting, we have been able to deliver workshops focussing on strategies which have helped providers to meet customer needs. In different workshops we have supported biotechs in developing a range of Target Product Profiles that address both clinical and partnering priorities.
Additionally, we have been using Immunoconsulting’s expertise for the benefit of clients as part of our R&D network.
TherapeutAix began collaborating with Alderley Analytical in 2020. We formed a dedicated project team after successfully joining forces to help a client overcome an unusual and challenging PK/PD situation.
"Joining the TherapeutAix team’s workshops is energising as it's enjoyable using our collective experience and perspectives to help clients achieve their goals."
Andrew Leishman, Immunoconsulting Limited Director